Works matching IS 18129269 AND DT 2023 AND VI 45 AND IP 1
Results: 14
COMPARISON OF 2D AND 3D PRIMARY CELL CULTURES OBTAINED FROM EXPLANT OF HIGH-GRADE UROTHELIAL BLADDER CANCER.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 130, doi. 10.15407/exp-oncology.2023.01.130
- By:
- Publication type:
- Article
RECURRENT LENTIGO MALIGNA: CONSERVATIVE CONTINUOUS TREATMENT WITH IMIQUIMOD OR REPEATED SURGERY? A LONG-TERM FOLLOW-UP DERMOSCOPIC CASE STUDY.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 125, doi. 10.15407/exp-oncology.2023.01.125
- By:
- Publication type:
- Article
EXPRESSION OF ALU REPEAT IN BLOOD PLASMA OF PATIENTS WITH BREAST CANCER DURING NEOADJUVANT CHEMOTHERAPY: AN EXPLORATORY STUDY.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 120, doi. 10.15407/exp-oncology.2023.01.120
- By:
- Publication type:
- Article
SKELETAL MUSCLE SENSITIVITY TO WASTING INDUCED BY UROTHELIAL CARCINOMA.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 107, doi. 10.15407/exp-oncology.2023.01.107
- By:
- Publication type:
- Article
DIAGNOSTICS OF LYMPHOGENIC METASTASIS IN PATIENTS WITH RECTAL CANCER BY COMBINING MRI WITH BLOOD CEA ASSESSMENT.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 99, doi. 10.15407/exp-oncology.2023.01.099
- By:
- Publication type:
- Article
CANCER-ASSOCIATED ADIPOCYTES AND PROGNOSTIC VALUE OF PREOPERATIVE NEUTROPHIL-LYMPHOCYTE RATIO IN GASTRIC CANCER.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 88, doi. 10.15407/exp-oncology.2023.01.088
- By:
- Publication type:
- Article
EXPRESSION OF HEPATOCYTE GROWTH FACTOR AND C-MET RECEPTOR IN STROMAL FIBROBLASTS AND TUMOR CELLS OF ENDOMETRIAL CARCINOMA.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 79, doi. 10.15407/exp-oncology.2023.01.079
- By:
- Publication type:
- Article
FAMILIAL NON-MEDULLARY THYROID CARCINOMA.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 70, doi. 10.15407/exp-oncology.2023.01.070
- By:
- Publication type:
- Article
NEW DATA ON HISTOGENESIS AND HISTOLOGICAL STRUCTURE OF LUNG CANCER.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 62, doi. 10.15407/exp-oncology.2023.01.062
- By:
- Publication type:
- Article
ROLE OF STROMAL MICROENVIRONMENT IN THE FORMATION OF INVASIVE, ANGIOGENIC, AND METASTATIC POTENTIAL OF ENDOMETRIOID CARCINOMA OF ENDOMETRIUM.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 51, doi. 10.15407/exp-oncology.2023.01.051
- By:
- Publication type:
- Article
EXPRESSION OF PROGRAMMED CELL DEATH RECEPTOR IN ENDOMETRIAL CANCER PATIENTS WITH METABOLIC DISORDERS.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 44, doi. 10.15407/exp-oncology.2023.01.044
- By:
- Publication type:
- Article
ABERRANT EXPRESSION OF COL14A1, CELRS3, and CTHRC1 IN BREAST CANCER CELLS.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 28, doi. 10.15407/exp-oncology.2023.01.028
- By:
- Publication type:
- Article
PATTERN OF MMP2 AND MMP9 EXPRESSION DEPENDS ON BREAST CANCER PATIENTS' AGE.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 17, doi. 10.15407/exp-oncology.2023.01.017
- By:
- Publication type:
- Article
NEUROENDOCRINE PEPTIDES IN THE PATHOGENESIS OF COLORECTAL CARCINOMA.
- Published in:
- Experimental Oncology, 2023, v. 45, n. 1, p. 3, doi. 10.15407/exp-oncology.2023.01.003
- By:
- Publication type:
- Article